Amy Mc Bride Wendell is Director of Axogen, Inc.. Currently has a direct ownership of 90,995 shares of AXGN, which is worth approximately $658,803. The most recent transaction as insider was on Jun 06, 2024, when has been sold 10,653 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91K
13.26% 3M change
29.36% 12M change
Total Value Held $658,803

Amy McBride Wendell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
10,653 Added 10.48%
90,995 Common Stock
Sep 06 2023
BUY
Open market or private purchase
$62,200 $6.22 p/Share
10,000 Added 11.07%
80,342 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
6,459 Added 8.41%
70,342 Common Stock
May 12 2023
BUY
Exercise of conversion of derivative security
$265,075 $9.22 p/Share
28,750 Added 31.04%
63,883 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
-
3,036 Added 7.95%
35,133 Common Stock
Jun 01 2021
BUY
Exercise of conversion of derivative security
-
6,173 Added 16.13%
32,097 Common Stock

Also insider at

HOLX
HOLOGIC INC Healthcare
BAX
BAXTER INTERNATIONAL INC Healthcare
SOLV
Solventum Corp
AMW

Amy Mc Bride Wendell

Director
Marlborough, MA

Track Institutional and Insider Activities on AXGN

Follow Axogen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

News

Receive news related to Axogen, Inc.

Track Activities on AXGN